BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22444200)

  • 1. Chitosan-based gastroretentive floating drug delivery technology: an updated review.
    Pahwa R; Saini N; Kumar V; Kohli K
    Expert Opin Drug Deliv; 2012 May; 9(5):525-39. PubMed ID: 22444200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industrial perspective of gastroretentive drug delivery systems: physicochemical, biopharmaceutical, technological and regulatory consideration.
    Pawar VK; Kansal S; Asthana S; Chourasia MK
    Expert Opin Drug Deliv; 2012 May; 9(5):551-65. PubMed ID: 22512596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excipients with specialized functions for effective drug delivery.
    Hamman J; Steenekamp J
    Expert Opin Drug Deliv; 2012 Feb; 9(2):219-30. PubMed ID: 22196483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ gel systems as 'smart' carriers for sustained ocular drug delivery.
    Agrawal AK; Das M; Jain S
    Expert Opin Drug Deliv; 2012 Apr; 9(4):383-402. PubMed ID: 22432690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential aspects of chitosan as pharmaceutical excipient.
    Ray SD
    Acta Pol Pharm; 2011; 68(5):619-22. PubMed ID: 21928704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.
    Thombre NA; Gide PS
    Drug Deliv; 2016; 23(2):405-19. PubMed ID: 24870198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of alginate-chitosan gastric floating beads loading with oxymatrine solid dispersion.
    Liu Y; Chen L; Zhou C; Yang J; Hou Y; Wang W
    Drug Dev Ind Pharm; 2016; 42(3):456-63. PubMed ID: 26422447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances and patent perspectives in gastroretentive technology.
    Pahwa R; Singh M; Kumar V; Kohli K
    Recent Pat Drug Deliv Formul; 2012 Dec; 6(3):278-90. PubMed ID: 22563754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
    Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
    Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.
    El Nabarawi MA; Teaima MH; Abd El-Monem RA; El Nabarawy NA; Gaber DA
    Drug Des Devel Ther; 2017; 11():1081-1093. PubMed ID: 28435220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroretentive floating drug-delivery systems: a critical review.
    Kotreka UK; Adeyeye MC
    Crit Rev Ther Drug Carrier Syst; 2011; 28(1):47-99. PubMed ID: 21395515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highlighting the impact of chitosan on the development of gastroretentive drug delivery systems.
    Souza MPC; Sábio RM; Ribeiro TC; Santos AMD; Meneguin AB; Chorilli M
    Int J Biol Macromol; 2020 Sep; 159():804-822. PubMed ID: 32425271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Overview on Various Approaches and Recent Patents on Gastroretentive Drug Delivery Systems.
    Kumar M; Kaushik D
    Recent Pat Drug Deliv Formul; 2018; 12(2):84-92. PubMed ID: 29521255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems.
    Pawar VK; Kansal S; Garg G; Awasthi R; Singodia D; Kulkarni GT
    Drug Deliv; 2011 Feb; 18(2):97-110. PubMed ID: 20958237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excipient pharmacokinetics and profiling.
    Loftsson T
    Int J Pharm; 2015 Mar; 480(1-2):48-54. PubMed ID: 25596414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QbD-Oriented Development and Characterization of Effervescent Floating-Bioadhesive Tablets of Cefuroxime Axetil.
    Bansal S; Beg S; Garg B; Asthana A; Asthana GS; Singh B
    AAPS PharmSciTech; 2016 Oct; 17(5):1086-99. PubMed ID: 26527606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are chitosan formulations mucoadhesive in the human small intestine? An evaluation based on gamma scintigraphy.
    Säkkinen M; Marvola J; Kanerva H; Lindevall K; Ahonen A; Marvola M
    Int J Pharm; 2006 Jan; 307(2):285-91. PubMed ID: 16310992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan: a unique polysaccharide for drug delivery.
    Felt O; Buri P; Gurny R
    Drug Dev Ind Pharm; 1998 Nov; 24(11):979-93. PubMed ID: 9876553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico and in vitro methods to optimize the performance of experimental gastroretentive floating mini-tablets.
    Eberle VA; Häring A; Schoelkopf J; Gane PA; Huwyler J; Puchkov M
    Drug Dev Ind Pharm; 2016; 42(5):808-17. PubMed ID: 26307090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan and its derivatives as vehicles for drug delivery.
    Huang G; Liu Y; Chen L
    Drug Deliv; 2017; 24(sup1):108-113. PubMed ID: 29124981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.